Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000128165 | SCV000171757 | benign | not specified | 2012-11-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000128165 | SCV000311295 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000251402 | SCV000317351 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-03-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000251402 | SCV000393489 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000362675 | SCV000393490 | likely benign | Loeys-Dietz syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000251402 | SCV000556217 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2025-02-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000755393 | SCV000605216 | benign | Aneurysm-osteoarthritis syndrome | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000251402 | SCV000910588 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-03-09 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000128165 | SCV001362470 | benign | not specified | 2019-10-22 | criteria provided, single submitter | clinical testing | Variant summary: SMAD3 c.870C>T (p.Ile290Ile) alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.016 in 246116 control chromosomes, predominantly at a frequency of 0.024 within the Non-Finnish European subpopulation in the gnomAD database, including 29 homozygotes. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 640 fold of the estimated maximal expected allele frequency for a pathogenic variant in SMAD3 causing Aortopathy phenotype (3.8e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. To our knowledge, no occurrence of c.870C>T in individuals affected with Aortopathy and no experimental evidence demonstrating its impact on protein function have been reported. Five ClinVar submissions (evaluation after 2014) cite the variant four times as benign and once as likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Genome Diagnostics Laboratory, |
RCV002277276 | SCV002566108 | benign | Ehlers-Danlos syndrome | 2022-06-30 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000251402 | SCV004239710 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-11-04 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000755393 | SCV004815393 | benign | Aneurysm-osteoarthritis syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001572817 | SCV005210969 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001572817 | SCV001797776 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000128165 | SCV001809544 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000128165 | SCV001932928 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000128165 | SCV001970082 | benign | not specified | no assertion criteria provided | clinical testing |